Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safety and current status of blood transfusion in China.

Literature DB >> 20347128

Safety and current status of blood transfusion in China.

Xuerong Yu¹, Yuguang Huang, Ge Qu, Jiaying Xu, Shangyi Hui.

Abstract

Mesh：

Year: 2010 PMID： 20347128 DOI： 10.1016/S0140-6736(10)60003-7

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. Blood donor management in china.

Authors: Ling Shi; Jingxing Wang; Zhong Liu; Lori Stevens; Andrew Sadler; Paul Ness; Hua Shan
Journal: Transfus Med Hemother Date: 2014-07-04 Impact factor: 3.747

2. Analysis of Chinese donors' return behavior.

Authors: Nan Guo; Jingxing Wang; Paul Ness; Fuzhu Yao; Xiangdong Dong; Xinhong Bi; Heili Mei; Julin Li; Weilan He; Yunlai Lu; Hongli Ma; Xiuqiong Wen; Mei Huang; David J Wright; Melissa King; Patrick High; Kenrad Nelson; Hua Shan
Journal: Transfusion Date: 2010-09-16 Impact factor: 3.157

3. Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.

Authors: Jingxing Wang; Jing Liu; Fuzhu Yao; Guoxin Wen; Julin Li; Yi Huang; Yunlai Lü; Xiuqiong Wen; David Wright; Qilu Yu; Nan Guo; Paul Ness; Hua Shan
Journal: Transfusion Date: 2012-11-01 Impact factor: 3.157

4. An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors.

Authors: Jingxing Wang; Jing Liu; Yi Huang; Tonghan Yang; Fuzhu Yao; Xiangdong Dong; Guoxin Wen; Xinhong Bi; Mingjiang Zhao; Xiuqiong Wen; Mei Huang; Yunlai Lü; Hongli Ma; Qilu Yu; David Wright; Nan Guo; Paul Ness; Hua Shan
Journal: Transfusion Date: 2013-01-10 Impact factor: 3.157

Review 5. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors: Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal: J Epidemiol Date: 2011-10-22 Impact factor: 3.211

10. Estimation of the number of blood donors during the COVID-19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission.

Authors: Zhaohu Yuan; Dandan Chen; Xiaojie Chen; Yaming Wei
Journal: Transfusion Date: 2020-05-22 Impact factor: 3.337

Safety and current status of blood transfusion in China.

Review 1. Blood donor management in china.

2. Analysis of Chinese donors' return behavior.

3. Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.

4. An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors.

Review 5. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Review 6. Perioperative Red Blood Cell Transfusion: What We Do Not Know.

7. Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patients.

8. The official websites of blood centers in China: A nationwide cross-sectional study.

9. Improvements in blood transfusion management: cross-sectional data analysis from nine hospitals in Zhejiang, China.

10. Estimation of the number of blood donors during the COVID-19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission.